| 
 
About Biocompatible Fabric - The 
Future Of Medical Textiles? 
  
Healthcare fabrics is one of the fastest growing 
segments of the medical textile industry. In fact, 2020 saw the global medical 
textiles market size valued at USD 24.70 billion, with forecasts predicting its 
continued expansion at a CAGR of 4.5% to 2028. 
  
This staggering growth is owing to the increased 
need for better wound closure devices that feature faster healing times and 
lower incidences of failure and infection, compounded by a growing demand for 
better healthcare services and more efficient medical treatments. 
  
The largest share of 2020’s global revenue came from 
the nonwoven segment with a 65% hold, and a prediction for the fastest growth in 
the forecast period. The non-implantable goods segment, meanwhile, is expected 
to register a revenue based CAGR of 4.4%, with demand driven by an increasing 
number of surgeries and subsequently a growing need to protect wounds and 
stitches from the external environment. 
  
Newer approaches and innovations in surgical 
adhesives and sealants continue to grow, with both momentum and market share 
building. 
  
Many of these developments – polymer-based 
nanofabrication, is one example – have sought to address the issues typically 
associated with traditional medical fabrics (such as their inability to prevent 
bacteria from accessing the wound site, which can lead to infection), while 
simultaneously providing additional clinical benefits. As the use of 
nanomaterials in biomedical applications gains widespread adoption, yearly 
market revenue is expected to increase. This will subsequently break down the 
primary barriers to take up – cost and scalability – as further research is 
conducted and development processes are streamlined. 
  
Developments in biocompatibility 
  
Polymeric nanomaterials, for example, have been 
researched extensively for a wide range of clinical applications, such as in 
drug delivery systems and tissue-engineering scaffolds, thanks to their 
biocompatibility and non-reactivity. 
  
Biocompatibility challenges with medical fabrics 
  
Biocompatible fabrics are important tools for the 
healthcare industry, used widely within diagnostics applications, wound care 
management, blood filters, and even implantable devices. To be deemed safe for 
use, these fabrics must pass all relevant biocompatibility tests and must be 
non-cytotoxic, non-hemolytic, non-pyrogenic, and show no sensitisation. Download 
this whitepaper to find out what goes into manufacturing biocompatible fabrics 
for the medical industry, including the complex washing and testing process. 
  
According to Piotr Gasiorczyk business development 
manager at leading manufacturer of precision fabrics Sefar Inc: “Today, 
biocompatible medical fabric is mostly used for high-precision applications, 
such as heart surgery. Many of these product advancements come from unique 
applications or unique customer requests which allow for a wider range of use of 
medical fabrics.” 
  
The use of biocompatible fabrics requires careful 
navigation of certain certification and regulations. 
  
Its applications include implants, medical devices, 
blood filtration, security filters into infusion sets, and applications for cell 
growth. 
  
In the coming years, there will be an ever-growing 
need for more biocompatible wound healing devices that promote robust patient 
recovery while preventing the need for expensive interventions to treat 
infections. Recent innovations will markedly improve the quality of surgical 
adhesives and sealants, which are important segments already capturing 
significant shares of the wound care market. 
  
https://www.medicaldevicenetwork.com/sponsored/biocompatible-fabric-the-future-of-medical-textiles/ 
  
                   |